Research spanning over 40 years demonstrates GHK-Cu affects more than 31% of human genes, with documented benefits including a 70% increase in collagen production, 30-50% faster wound healing, and hair growth comparable to 5% minoxidil
Pairs beautifully with in-office treatments Clients who want maximum remodeling often combine GHK-Cu protocols with Morpheus8 Burst, Quantum RF, or Solaria CO2 your NP builds one coordinated plan instead of disconnected treatments
44 Orforglipron In a phase 2, randomized, double-blind trial, daily oral orforglipron (12, 24, 36, or 45 mg) for 36 weeks led to weight reductions of 9.414.7% in adults with pre-obesity or obesity (without diabetes), compared to 2.3% with placebo, and showed no signs of plateau (Table 2)
If you're exploring a more structured solution, you can explore peptide therapy for brain fog here: 2
A pharmacy operating under USP 797 Category 3 conditions with validated stability data can assign longer BUDs
CagriSema is still in the research phase and has not yet been approved by the FDA